Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medical Mycology Case Reports|January 17, 2014
Cutaneous protothecosis in a patient with hypogammaglobulinemiaJason C Kwong, Peter B Ward, Paul D Johnson
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failurePeter G Kelley, Wei Gao, Peter B Ward, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremiaBenjamin P Howden, Paul D R Johnson, Peter B Ward, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureusPatrick G P Charles, Peter B Ward, Paul D R Johnson, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureusBenjamin P Howden, Timothy P Stinear, David L Allen, et al.
BMC Microbiology|February 29, 2008
Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemiaBenjamin P Howden, Danielle J Smith, Ashley Mansell, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|June 2, 2018
Impact of unit-wide chlorhexidine bathing in intensive care on bloodstream infection and drug-resistant organism acquisitionKaren F Urbancic, Johan Mårtensson, Neil Glassford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Pageof 1